
Bioorganic and Medicinal Chemistry Letters p. 4955 - 4961 (2012)
Update date:2022-08-03
Topics:
Mittapalli, Gopi Kumar
Zhao, Fang
Jackson, Andrew
Gao, Hongfeng
Lee, Haekyung
Chow, Stephine
Kaur, Maninder Pal
Nguyen, Natalie
Zamboni, Robert
McKelvy, Jeffrey
Wong-Staal, Flossie
MacDonald, James E.
The manuscript reports an identification of a highly potent, orally bioavailable hepatitis C virus entry inhibitor through optimization of a previously reported class of molecules (1) that were not stable in the rat plasma. Compound 39 (ITX 4520) exhibited an excellent PK profile in both rats and dogs with good oral exposure, half-life and oral bioavailability. The compound is also well-tolerated in the preliminary in vivo toxicity studies and has been selected as a pre-clinical candidate for our HCV clinical pipeline.
View MoreSuzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Jiangxi Hessence Chemicals Co., Ltd.
Contact:+86 796 3511924
Address:Chengxi Industrial Park, Jishui County, Jiangxi Province 331600 China.
shanghai Tauto Biotech Co., Ltd
website:http://www.tautobiotech.com/en/index.htm
Contact:+86-21-51320588 ext. 8025
Address:No. 326, Aidisheng Rd , Zhangjiang Hi-tech Park, Shanghai , P.R.CHINA
Taizhou Shengxing Chempharm Co.,Ltd
Contact:+86-576-88516600
Address:Yantou Chemical Zone Jiaojiang Taizhou Zhejiang China
Doi:10.1016/j.ejmech.2012.04.032
(2012)Doi:10.1246/cl.1992.167
(1992)Doi:10.1021/jm00147a028
(1985)Doi:10.1021/acs.jmedchem.7b00533
(2017)Doi:10.1002/anie.201200309
(2012)Doi:10.1021/ic300400v
(2012)